Australia's Sigma jumps after offering to address regulatory concerns with Chemist Warehouse merger
Recasts paragraph1, adds shares in paragraph 2
Oct 1 (Reuters) -Australia's Sigma Healthcare SIG.AX jumped 13% on Tuesday after it offered a court-enforceable undertaking to address the antitrust regulator's concerns about its proposed merger with Chemist Warehouse to form an A$8.8 billion ($6.09 billion) company.
Shares of Sigma soared as much as 12.9% as of 0041 GMT, their highest level since April 2007, and were the best performers on the benchmark index, which was down 0.5%.
The Australian Competition and Consumer Commission (ACCC), in its preliminary findings published in June, said the deal could leave pharmacies outside the merged group facing rising costs, which would lead them to be less competitive.
The regulator had said it was worried that the merged group would have access to the commercially sensitive data of Sigma's existing pharmacy customers.
Under the proposed undertaking, Sigma would restrict the collection and use of confidential data from its wholesale customers and franchisees for three years, and also allow franchisees to terminate their agreements, the competition regulator said.
The ACCC said it was seeking feedback from stakeholders on whether the draft undertaking offered by Sigma might be capable of addressing the competition concerns.
Chemist Warehouse is a privately owned pharmacy and retail chain in Australia known for cheap prices and large stores, while Sigma is a wholesaler and distributor of prescription medicines and other products.
The proposed deal, announced in December, would see Sigma acquiring Chemist Warehouse in exchange for a stake in the company and A$700 million in cash, allowing Chemist Warehouse to be effectively backdoor listed through Sigma.
Acknowledging the ACCC's decision to start a consultation process, Sigma said it would work co-operatively with the regulator.
To facilitate consultation, the proposed date for the ACCC's decision on the merger has been extended to Nov. 7 from Oct. 24.
($1 = 1.4455 Australian dollars)
Reporting by Himanshi Akhand in Bengaluru; Editing by Subhranshu Sahu and Alan Barona
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
